Biofrontera Inc. (BFRI) vs Cerenome, Inc. (CNSY)
A side-by-side comparison of Biofrontera Inc. and Cerenome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BFRI
Biofrontera Inc.
$0.89HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CNSY
Cerenome, Inc.
$1.56HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BFRI vs CNSY
growth of $100 · dividends reinvested · last 1yBFRI -23.2% (-23.2%/yr)CNSY -61.5% (-61.5%/yr)BFRI compounded faster over this window
BFRI CNSY
BFRI vs CNSY: by the numbers
- •BFRI is the larger company ($11M vs $11M market cap).
- •Both run net losses; BFRI's is the smaller (-13.78% vs -620.70% net margin).
Metrics side by side
Valuation
| Metric | BFRI | CNSY |
|---|---|---|
| P/S ratio | 0.25 | 2.55 |
| P/B ratio | 1.92 | 1.97 |
Profitability
| Metric | BFRI | CNSY |
|---|---|---|
| Gross margin | 84.45% | 89.58% |
| Operating margin | -21.94% | -293.46% |
| Net margin | -13.78% | -620.70% |
| ROE | -106.87% | -477.54% |
| ROIC | -32.27% | -479.39% |
Growth (annualized)
| Metric | BFRI | CNSY |
|---|---|---|
| Revenue CAGR (5Y) | 15.55% | N/A |
Go deeper
Dig into the metrics
Biofrontera ROECerenome ROEBiofrontera operating marginCerenome operating marginBiofrontera revenue growthCerenome revenue growthBiofrontera free cash flowCerenome free cash flow
Biofrontera & Cerenome appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.